Medfin India: Financial Breakdown
Decoding financial health metrics of Medfin India
Total Revenue₹10.2 Cr+122%Prev. FY
Total Expenses₹56.7 Cr+137%Prev. FY
Profit After Tax₹-46.5 Cr+-141%Prev. FY
Total Assets₹64.0 Cr+8%Prev. FY
Net Profit Margin-456.8%-9%Prev. FY
FAQs on Financials of Medfin India
No. In FY23, Medfin India reported a net loss of ₹46.5 Cr+, so it was not profitable.
Medfin India's revenue grew 122.5% year-on-year, from ₹4.6 Cr+ in FY22 to ₹10.2 Cr+ in FY23.
Medfin India's estimated EBITDA for FY23 was ₹-45.7 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY23, Medfin India posted revenue of ₹10.2 Cr+ (up 122.5% YoY) and a net loss of ₹46.5 Cr+. Explore the full financials of Medfin India here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links